PPL Corporation rate hike approved, shares priced for grid investment
PPL Corporation has received approval for new Pennsylvania distribution rates, effective July 1, 2026, which are expected to boost annual revenue by $275 million. This revenue will primarily fund grid upgrades and support the growing demand from data centers. The company plans to report its next quarterly earnings around July 30, 2026, and its shares, trading around $37.00, are anticipated to reflect these infrastructure investments.
Ford considering $2 billion expansion at Louisville plant
Ford Motor Co. is evaluating a potential $2 billion investment to expand operations at its Kentucky Truck Plant in Louisville, according to Gov. Andy Beshear. This investment would broaden manufacturing at the Chamberlain Lane site and develop an adjacent 70-acre property purchased by Ford in 2025. This proposed project follows a previous $2 billion upgrade announced last August to prepare for electric pickup production, though the latest expansion is still under evaluation.
Bernstein Initiates Coverage on PepsiCo (PEP) as International Strength Offsets North America Challenges
Bernstein SocGen Group initiated coverage on PepsiCo (PEP) with a Market Perform rating and a $143 price objective. The firm highlighted challenges in PepsiCo's North American snacking industry, noting market dominance loss, but acknowledged the strong and profitable international business. Bernstein anticipates a 3% year-over-year EPS increase for the next two years, and Barclays analysts believe consumer product companies like PepsiCo can manage rising input costs while maintaining profit margins.
Morgan Stanley and Stifel Raise Confidence in Philip Morris (PM) Ahead of ZYN Ultra Launch and IQOS Expansion
Morgan Stanley and Stifel have increased their confidence in Philip Morris (PM), raising price targets and reaffirming Buy ratings. This optimism stems from the upcoming launch of Zyn Ultra in the U.S. and the planned revamp of IQOS in Japan. The new Zyn Ultra is expected to boost Philip Morris's market share and reduce the product and value gap with competitors.
Williams Companies consensus stays steady, shares in S&P 500 energy focus
Williams Companies remains a key midstream player in the S&P 500 energy sector, with its shares trading on the NYSE under WMB. Despite a Q1 2026 revenue miss, the company beat EPS estimates, leading to a neutral "Hold" rating from Zacks Investment Research. The company primarily generates cash flow through natural gas transmission, gathering, and processing via long-term, fee-based contracts.
What the federal government's quantum push means for Chicago
The federal government has recently designated quantum technology as a national priority, a decision expected to have significant implications for Chicago and Illinois. This push could accelerate the growth of the tech hub in the region. Infleqtion, a company that recently raised $550 million in its IPO, is already experiencing increased federal interest as a result of this initiative.
Revvity (RVTY) Coverage Initiated by Bernstein with $115 Target
Bernstein has restarted coverage of Revvity Inc (RVTY) with a Market Perform rating and a $115 price target, citing positive shifts in the life sciences tools and diagnostics sector fueled by increased drug approvals and funding. Despite an optimistic industry outlook, investors are advised to consider Revvity's high P/E ratio and recent insider selling activity, even with its solid GF Score of 75. The company, formed from PerkinElmer's rebranding, supplies reagents and instruments for research and diagnostics globally.
Form DEF 14A THE J. M. SMUCKER COMPANY For: 26 June By Investing.com
This article announces the filing of Form DEF 14A for The J. M. Smucker Company on June 26. It is a brief, boilerplate notification provided by Investing.com, likely summarizing a regulatory filing. The content focuses on the event itself rather than offering detailed analysis or financial information.
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target
Bernstein has resumed coverage of Thermo Fisher Scientific Inc (TMO) with a Market Perform rating and a $520 price target, citing positive momentum in the life sciences tools and diagnostics sector due to increased drug approvals, clinical trials, and funding. Thermo Fisher exhibits strong profitability and growth with a GF Score of 83/100, though its financial strength is moderate and recent insider activity shows only selling. Investors are advised to consider these mixed signals when evaluating TMO.
Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs Actuals & Estimates (BCBA:CLC)
This page provides an overview of the financial actuals and estimates for Colgate-Palmolive Company Shs Cert.Deposito Arg.Repr. 0.3333 Shs (BCBA:CLC). It allows users to explore reported financial data and analyst estimates across the income statement, balance sheet, cash flow statement, and valuation metrics, comparing actual results with average, high, and low estimates. The disclaimer notes that the information is not investment advice and is for informational purposes only.





